Source: Eur Respir J 2011; 38: 246-247



Rating:

Share or cite this content

Citations should be made in the following way:
Hegele R.G.. Respiratory syncytial virus therapy and prophylaxis: have we finally turned the corner?. Eur Respir J 2011; 38: 246-247

Member's Comments

No comment yet.

Related content which might interest you: Respiratory syncytial virus (RSV) prophylaxis in special populations Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions Year: 2011 Rhinovirus infections in infants: is respiratory syncytial virus ready for the challenge? Source: Eur Respir J 2008; 32: 249-251 Year: 2008 Respiratory syncytial virus: a sleeping giant? Source: Eur Respir J 2007; 30: 1029-1031 Year: 2007 Respiratory syncytial virus: still a global burden for children Source: Breathe 2010; 7: 96 Year: 2010 Respiratory syncytial virus and subsequent asthma: one step closer to unravelling the Gordian knot? Source: Eur Respir J 2002; 20: 515-517 Year: 2002 Palivizumab: Is it cost effective to extend the vaccination period for patients at risk of severe respiratory syncytial virus infection? Source: Virtual Congress 2021 – Acute and chronic lung infections in children Year: 2021 Respiratory infections in children: from respiratory syncytial virus to tuberculosis Source: International Congress 2019 – Paediatric Year in review Year: 2019 Respiratory syncytial virus: co-infection and paediatric lower respiratory tract infections Source: Eur Respir J 2013; 42: 461-469 Year: 2013 Respiratory syncytial virus: a common threat Source: Annual Congress 2011 - PG17 Emerging infections: educational perspectives Year: 2011 Respiratory syncytial virus Source: Eur Respir Monogr 2016; 72: 84-109 Year: 2016 Respiratory syncytial virus: types and genotypes of the virus in infants hospitalized with lower respiratory tract infection in Brazil Source: Eur Respir J 2005; 26: Suppl. 49, 27s Year: 2005 Prophylaxis against respiratory syncytial virus in high-risk infants Source: Eur Respir Monogr 2021; 92: 361-371 Year: 2021 Inhaled and small molecules therapeutics to fight respiratory syncytial virus infection in newborn lung Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments Year: 2019 Respiratory syncytial virus infection in childcare and hospitalized children with different respiratory disease severity Source: Annual Congress 2006 - Virus-induced respiratory tract infection Year: 2006 Respiratory syncytial virus (RSV): innocent bystander or an inducer of asthma and allergy? Source: Annual Congress 2007 - Viruses and childhood asthma Year: 2007 Ribavirin therapy for respiratory syncitial virus infection after lung transplantation Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 Respiratory syncytial virus prophylaxis in Down syndrome: A prospective cohort study Source: International Congress 2014 – Paediatric epidemiology: new insights into primary ciliary dyskinesia, prematurity and bronchiolitis Year: 2014 Cromoglycate in the treatment of respiratory syncytial virus (RSV) bronchiolitis Source: Eur Respir J 2001; 18: Suppl. 33, 169s Year: 2001 Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model Source: Eur Respir J 2011; 38: 401-408 Year: 2011 Infantile respiratory syncytial virus and human rhinovirus infections: respective role in inception and persistence of wheezing Source: Eur Respir J 2015; 45: 774-789 Year: 2015